Cancer Advances
  • Home
  • About
  • Our Science
    • Recent Publications
    • Our Target
    • Our Product
  • News & Events
  • Contact
Select Page

April 9, 2021 – Cancer Advances, Inc. Announces Minisymposium Presentation at AACR

Apr 13, 2021 | Press Releases

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse...
Next Entries »

Recent Posts

  • Cancer Advances, Inc. Announces Issuance of New U.S. Patent
  • Cancer Advances, Inc. Announces Abstract and Poster Presentation at ASCO GI – Role of an anti-gastrin vaccine (PAS) in combination with a PD-1 antibody on growth and metastasis of gastric cancer
  • Cancer Advances, Inc. Announces Publication, “Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer” in Frontiers in Oncology
  • Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model
  • Vaccination with Polyclonal Antibody Stimulator PAS Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model

Recent Comments

    © 2020 Cancer Advances, Inc. All rights reserved.